The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis
Explore this paper's citation graph
Summary
ProNGF levels in serum and biopsy-rinse are not increased in thyroid cancer and therefore proNGF is not a clinical biomarker for this condition.
- Type
- article
- Published
- 2019-06-20
- Cited by
- 2
- References
- 36
- Access
- Open access
- OpenAlex
- https://openalex.org/W2989742142
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:208017294
Keywords
Medicine, Biomarker, Diabetes mellitus, Thyroid cancer, Nerve growth factor
References
- Serum biomarkers of papillary thyroid cancer
- Thyroid hormone and androgen regulation of nerve growth factor gene expression in the mouse submandibular gland.
- Thyroid hormones precociously increase nerve growth factor gene expression in the submandibular gland of neonatal mice.
- Diagnosis of Medullary Thyroid Carcinoma by Calcitonin Measurement in Fine-Needle Aspiration Biopsy Specimens
- Neurotrophins and their receptors stimulate melanoma cell proliferation and migration.
- Imbalance of the Nerve Growth Factor and Its Precursor as a Potential Biomarker for Diabetic Retinopathy
- Epidemiology of thyroid nodules.
- Nerve growth factor concentration in human saliva.
- Effect of thyroxine on nerve growth factor concentration in neonatal mouse brain.
- Pro-nerve Growth Factor Induces Autocrine Stimulation of Breast Cancer Cell Invasion through Tropomyosin-related Kinase A (TrkA) and Sortilin Protein*
- Neurotrophins and their receptors in breast cancer.
- Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results.
- Comparative studies on testosterone and L-thyroxine effects on the synthesis of nerve growth factor in mouse submaxillary salivary glands.
- Synthesis of nerve growth factor mRNA and precursor protein in the thyroid and parathyroid glands of the rat.
- Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
- Effect of thyroxine, testosterone, and corticosterone on nerve growth factor (NGF) and epidermal growth factor (EGF) concentrations in adult female mouse submaxillary gland: dissociation of NGF and EGF responses.
- ProNGF correlates with Gleason score and is a potential driver of nerve infiltration in prostate cancer.
- HIGH LEVEL OF A NERVE GROWTH FACTOR IN THE SERUM OF A PATIENT WITH MEDULLARY CARCINOMA OF THE THYROID GLAND
- High levels of the proNGF peptides LIP1 and LIP2 in the serum and synovial fluid of rheumatoid arthritis patients: evidence for two new cytokines.
- Nerve Growth Factor and proNGF Simultaneously Promote Symmetric Self‐Renewal, Quiescence, and Epithelial to Mesenchymal Transition to Enlarge the Breast Cancer Stem Cell Compartment
Cited by
Related papers
- Intraventricular infusion of nerve growth factor (NGF)
- 7S nerve growth factor has different biological activity from 2.5S nerve growth factor in vitro.
- Effect of nerve growth factor on lesioned PC12 cells.
- Nerve growth factor expression in astrocytoma and cerebrospinal fluid： a new biomarker for prognosis of astrocytoma
- Advances in Studies on Neuronal Protective Mechanisms of Nerve Growth Factor and It's Clinical Application
- Distribution of nerve growth factor in cat brains following topical application of solution or Minipellet.
- Preparation and Property of Injected Controlled Release of Nerve Growth Factor
- Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons.